AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
176.95
+5.22 (3.04%)
At close: Nov 22, 2024, 4:00 PM
177.40
+0.45 (0.25%)
After-hours: Nov 22, 2024, 7:57 PM EST
AbbVie Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for AbbVie stock have an average target of 206, with a low estimate of 173 and a high estimate of 225. The average target predicts an increase of 16.42% from the current stock price of 176.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 8 | 9 |
| Buy | 8 | 9 | 9 | 9 | 9 | 11 |
| Hold | 1 | 1 | 1 | 1 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 20 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $206 | Hold → Buy | Upgrades | $206 | +16.42% | Nov 22, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $205 | Buy | Initiates | $205 | +15.85% | Nov 15, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $210 → $200 | Buy | Maintains | $210 → $200 | +13.03% | Nov 13, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $226 → $215 | Strong Buy | Maintains | $226 → $215 | +21.50% | Nov 12, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $228 → $208 | Buy | Maintains | $228 → $208 | +17.55% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
57.18B
from 54.32B
Increased by 5.27%
Revenue Next Year
60.42B
from 57.18B
Increased by 5.65%
EPS This Year
11.16
from 2.72
Increased by 310.36%
EPS Next Year
12.37
from 11.16
Increased by 10.87%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 59.4B | 63.9B | 69.1B | ||
| Avg | 57.2B | 60.4B | 65.0B | ||
| Low | 54.7B | 55.1B | 60.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.4% | 11.8% | 14.3% | ||
| Avg | 5.3% | 5.7% | 7.5% | ||
| Low | 0.7% | -3.6% | -0.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.62 | 13.65 | 15.70 | ||
| Avg | 11.16 | 12.37 | 13.96 | ||
| Low | 10.68 | 11.30 | 12.81 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 327.3% | 22.3% | 26.8% | ||
| Avg | 310.4% | 10.9% | 12.8% | ||
| Low | 292.7% | 1.2% | 3.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.